Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,460 across all filing types
Latest filing 2026-04-22 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
公司章程（2026年4月）
Governance Information Classification · 100% confidence The document is a detailed company charter or articles of association for 华邦生命健康股份有限公司 (Huapont Life Sciences Co., Ltd.). It includes chapters on general provisions, business scope, shares issuance and transfer, shareholders and shareholders' meetings, board of directors, management, financial accounting, information disclosure, labor and social insurance, notices and announcements, mergers and reorganizations, amendments to the charter, and appendices. The content is legal and governance-related, focusing on the company's internal rules, shareholder rights, board structure, meeting procedures, and corporate governance practices. There is no indication of financial statements, audit reports, earnings data, or investor presentations. The document is not an announcement or a brief notice but a comprehensive governance document. Therefore, the most appropriate classification is Governance Information (CGR).
2026-04-22 Chinese
2025年度独立董事述职报告-黎明
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Report" for the year 2025 from Huabang Life Health Co., Ltd. It details the independent director's duties, attendance at meetings, oversight activities, communication with auditors, and evaluation of company governance and financial matters. It is a narrative report on the director's performance and oversight role rather than a financial report or announcement. It does not contain financial statements or earnings data, nor is it a notice or announcement of a report. It is a management-related report focusing on governance and oversight by an independent director. Therefore, it fits best under Board/Management Information (MANG). The document length is about 4755 characters, which is sufficient for a detailed report but not a full annual or interim financial report. Hence, the classification is MANG with high confidence.
2026-04-22 Chinese
资产减值准备计提及核销管理制度（2026年4月）
Governance Information Classification · 95% confidence The document is a detailed internal management system for asset impairment provision and write-off procedures of a company, including definitions, accounting standards, approval authorities, and disclosure obligations. It is a policy or governance document rather than a financial report, earnings release, or announcement. It does not contain financial statements or results, nor is it a regulatory filing or announcement of a report. The content focuses on internal rules and procedures related to asset impairment management, which aligns with governance information about company practices and board responsibilities. Therefore, the most appropriate classification is Governance Information (CGR).
2026-04-22 Chinese
独立董事专门会议工作制度（2026年4月）
Governance Information Classification · 95% confidence The document is a detailed internal governance policy titled 'Independent Directors Special Meeting Work System' for a company, outlining procedures, responsibilities, and meeting protocols for independent directors. It focuses on governance structure and internal rules rather than financial data, audit results, or shareholder meeting materials. It is not an announcement or a report of financial results, nor is it a regulatory filing or certification. The content fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2026-04-22 Chinese
对外提供财务资助管理办法（2026年4月）
Governance Information Classification · 95% confidence The document is titled as a management policy or internal regulation regarding the company's procedures for providing financial assistance externally. It outlines rules, approval processes, responsibilities, and disclosure requirements related to financial support activities. There are no financial statements, earnings data, or report summaries present. The document is a governance or procedural manual rather than a financial report or announcement. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Capital Update. It is best classified under Governance Information (CGR) as it details internal rules and governance practices related to financial assistance management.
2026-04-22 Chinese
募集资金使用管理办法（2026年4月）
Regulatory Filings Classification · 95% confidence The document is titled '募集资金使用管理办法' which translates to 'Fundraising Capital Usage Management Measures'. It details the rules, procedures, and governance related to the management and use of funds raised by the company, including regulatory references to Chinese securities laws and Shenzhen Stock Exchange rules. The content is a detailed policy or management guideline document rather than a financial report, earnings release, or announcement. It does not contain financial statements, earnings data, or voting results. It is not a report publication announcement or a certification. The document is a regulatory or compliance-related filing outlining internal controls and procedures for fundraising capital usage. Therefore, it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories.
2026-04-22 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.